Lyme Disease Brain Fog: Causes, Symptoms, and Treatment

Lyme disease can affect thinking and memory
Brain fog may fluctuate from day to day
Cognitive recovery varies after treatment

Lyme disease brain fog is a common cognitive complaint reported by patients. Many describe difficulty concentrating, slowed thinking, forgetfulness, trouble finding words, and reduced mental stamina.

Patients often describe brain fog as thinking through mud or watching their own thoughts disappear. It can strike suddenly or develop gradually, making routine mental tasks surprisingly exhausting.

Although many medical conditions can cause brain fog, Lyme disease is an important consideration when cognitive problems occur alongside fatigue, headaches, pain, dizziness, sleep disturbance, neurologic symptoms, or a history of possible tick exposure.

Brain fog is one of several cognitive symptoms associated with Lyme disease, including slowed processing speed, impaired attention, reduced mental stamina, forgetfulness, and difficulty finding words.

For a broader discussion of neurologic involvement—including neuroinflammation, meningitis, nerve-root involvement, and cognitive dysfunction—see How Lyme Disease Affects the Brain.

For a broader overview of symptoms, see the Lyme Disease Symptoms Guide.

Can Lyme disease cause brain fog?

Yes. Cognitive problems have been described in patients with Lyme disease and in some patients who continue to experience symptoms after treatment.^1-4

Patients may experience difficulty concentrating, slowed thinking, memory lapses, reduced processing speed, and trouble finding words.

Several mechanisms could potentially contribute, including neurologic involvement, inflammation, immune activation, autonomic dysfunction, sleep disruption, pain, fatigue, and other physiologic effects of illness.

Brain fog is therefore not necessarily an isolated brain symptom. It may occur as part of a broader illness involving fatigue, headaches, dizziness, sensory changes, sleep problems, pain, or autonomic symptoms.

How does Lyme disease brain fog feel?

Patients often describe being mentally present but unable to think at their usual speed. Words disappear mid-sentence. Thoughts drift. Reading becomes difficult. Tasks that once took minutes may require substantially more effort.

Common experiences include:

• Forgetting the name of someone you know well
• Reading the same paragraph repeatedly without retaining it
• Losing your train of thought while speaking
• Struggling to find ordinary words during conversation
• Walking into a room and forgetting why you went there
• Missing a familiar turn or exit while driving
• Forgetting appointments despite writing them down
• Having difficulty multitasking
• Feeling mentally exhausted after relatively minor cognitive activity

These symptoms may fluctuate from day to day and can become more noticeable with fatigue, poor sleep, illness flares, overstimulation, physical exertion, or physiologic stress.

Can Lyme disease cause memory loss?

Yes. Memory complaints have been reported in patients with Lyme disease, particularly when cognitive symptoms are part of a broader neurologic or persistent symptom syndrome.^1-3

Patients may report forgetting recent conversations, misplacing everyday objects, losing their train of thought, or struggling to retrieve information that previously came easily.

Memory problems frequently occur together with slowed processing speed, impaired attention, fatigue, word-finding difficulty, and reduced mental endurance.

Importantly, subjective cognitive symptoms do not always correspond neatly with abnormalities on standard neuropsychological testing. A patient can experience substantial difficulty functioning in daily life even when individual test scores fall within a laboratory reference range.

In some patients, cognitive symptoms become severe enough to raise concern about dementia or another neurodegenerative disorder. For a clinical discussion of that overlap, see Lyme Disease and Dementia.

Why is Lyme disease brain fog often misunderstood?

Brain fog is not specific to Lyme disease. Similar symptoms can occur with sleep disorders, medications, thyroid disease, anemia, depression, anxiety, ADHD, menopause, migraine, autoimmune disorders, long COVID, other infections, and neurodegenerative disease.

This broad differential diagnosis is one reason careful evaluation is important.

At the same time, cognitive complaints should not automatically be attributed to anxiety, stress, aging, or depression simply because routine blood tests, neurologic examinations, or brain imaging are unrevealing.

Lyme disease may produce symptoms that fluctuate and overlap with fatigue, pain, dizziness, sleep disruption, and autonomic dysfunction. That pattern can make the illness difficult to recognize when symptoms are evaluated individually rather than as part of the patient’s overall clinical history.

What might cause cognitive problems in Lyme disease?

Several overlapping mechanisms have been proposed to explain cognitive symptoms associated with Lyme disease.

These include:

• Neurologic involvement from Lyme neuroborreliosis
• Neuroinflammation and immune activation
• Autonomic dysfunction
• Sleep disruption
• Pain and fatigue
• Changes in cerebral blood flow or physiologic regulation
• Medication effects
• Other tick-borne infections or unrelated medical conditions

These mechanisms are unlikely to be identical in every patient.

Some patients with persistent symptoms after treatment meet criteria for post-treatment Lyme disease syndrome (PTLDS). The term describes a clinical syndrome but does not establish a single mechanism responsible for every patient’s symptoms.

Cognitive complaints may also overlap with autonomic dysfunction in Lyme disease, particularly when brain fog occurs with dizziness, orthostatic intolerance, tachycardia, exercise intolerance, temperature dysregulation, or gastrointestinal symptoms.

Can brain fog improve with Lyme disease treatment?

It can. Many patients report clearer thinking, better concentration, improved word recall, and greater mental stamina after treatment, although the degree and durability of improvement vary considerably.

Clinical trials investigating cognitive outcomes after additional antibiotic treatment have produced mixed results.^4-7

This distinction is important. The research does not show that every patient with persistent cognitive symptoms will improve with additional antibiotics. But it also does not support reducing the entire literature to a simple statement that cognition never improves with treatment.

What do antibiotic trials show about Lyme disease brain fog?

A 2023 systematic review by Rizvi and colleagues examined pharmacologic treatment of cognitive impairment in central nervous system infections. The review included five Lyme disease studies evaluating antibiotic treatment.⁴

The authors found evidence that antibiotics, alone or in combination with other medications, improved certain cognitive domains in some Lyme disease studies. However, they rated the overall certainty of the evidence as low because of limitations in study design, risk of bias, inconsistent findings, small samples, and differences in how cognition was measured.⁴

The review therefore did not establish that additional antibiotic treatment reliably improves cognitive symptoms in every patient. Instead, it highlighted how limited and heterogeneous the available evidence remains.

What did the Fallon Lyme encephalopathy trial find?

Fallon and colleagues studied patients with persistent cognitive impairment following previously treated Lyme disease in a randomized, placebo-controlled trial of repeated intravenous ceftriaxone.⁵

Patients receiving ceftriaxone showed greater improvement on a cognitive measure at the 12-week assessment. However, the treatment-placebo difference was no longer significant at the later 24-week evaluation.⁵

This finding is important because it suggests that cognitive improvement during or shortly after treatment may not always be sustained after treatment ends.

The trial does not tell us why the improvement was temporary or whether a different duration, regimen, patient population, or clinical endpoint would produce different results.

What did the Kaplan trial find?

Kaplan and colleagues evaluated cognitive function in 129 patients with persistent symptoms following previously treated Lyme disease.⁶

Participants received 30 days of intravenous ceftriaxone followed by 60 days of oral doxycycline or matching placebos.

Both antibiotic and placebo groups improved on several measures over time, but investigators found no significant cognitive advantage for additional antibiotic treatment compared with placebo.⁶

An important feature of this study was that participants reported substantial cognitive symptoms despite generally normal baseline neuropsychological test scores.

That discrepancy illustrates one of the challenges in studying Lyme disease brain fog: the cognitive difficulty patients experience in daily life may not always be captured by standardized testing.

What did the PLEASE trial find about cognition?

Berende and colleagues examined cognitive performance in 239 patients with persistent symptoms attributed to Lyme borreliosis.⁷

All participants initially received two weeks of intravenous ceftriaxone. They were then randomized to 12 additional weeks of doxycycline, clarithromycin plus hydroxychloroquine, or placebo.

Cognitive performance improved in several domains over time, but the improvement was not specific to the groups receiving longer antibiotic treatment. Longer treatment therefore did not produce better cognitive performance than the shorter regimen used in the study.⁷

This trial addresses one particular question—whether those longer regimens produced additional cognitive benefit in that study population. It does not establish the mechanism responsible for persistent symptoms in every patient or identify which individual patients may respond differently.

Why are the cognitive-treatment studies difficult to interpret?

There are several reasons the literature does not provide a simple answer.

The studies differ substantially in:

• How patients were selected
• Previous Lyme disease treatment
• Duration of persistent symptoms
• Antibiotic regimens and treatment duration
• Definitions of cognitive impairment
• Neuropsychological tests used
• Timing of follow-up
• Clinical outcomes considered important

The 2023 systematic review identified extensive variation in the cognitive outcome measures used across studies.⁴

Repeated neuropsychological testing can also produce practice effects, in which test performance improves partly because patients become familiar with the test rather than because the underlying illness has changed.

Another difficulty is the difference between objective cognitive testing and the patient’s ability to function in everyday life. A brief laboratory test may not fully reproduce the demands of working for several hours, reading complex material, multitasking, driving, studying, or maintaining concentration when fatigued.

Does improvement with antibiotics prove persistent infection?

No. A clinical response to treatment does not by itself establish the biological mechanism responsible for improvement.

Likewise, failure to improve with a particular antibiotic regimen does not by itself establish that all persistent symptoms are noninfectious.

Persistent cognitive problems following Lyme disease remain clinically heterogeneous. Possible explanations may include persistent infection in some patients, post-infectious inflammation or immune dysfunction, autonomic dysfunction, neurologic injury, sleep disturbance, other tick-borne infections, medication effects, or unrelated medical conditions.

The available treatment trials were not designed to resolve every one of these possibilities.

What I see in clinical practice

In my clinical practice, I have treated patients whose brain fog, memory problems, word-finding difficulty, and slowed thinking improved substantially with additional treatment. I have also treated patients who improved only partially or did not improve.

That variability is important.

Clinical trials provide valuable information about groups of patients, but they do not reliably identify in advance which individual patient will improve, how quickly improvement will occur, or whether an initial response will persist after treatment is stopped.

When cognitive symptoms remain disabling, I believe the patient deserves reassessment rather than having the symptoms automatically attributed to stress or assumed to be an unavoidable consequence of prior Lyme disease.

That reassessment should consider the original diagnosis, adequacy and response to previous treatment, possible reinfection, other tick-borne infections, neurologic and autonomic manifestations, medications, sleep, metabolic disorders, and alternative diagnoses.

Any decision regarding additional antibiotic treatment should weigh the potential benefit against medication adverse effects and, particularly with intravenous therapy, catheter-related and other treatment risks.

What should patients watch for?

When brain fog occurs together with fatigue, headaches, migrating pain, sleep disturbance, dizziness, or sensory hypersensitivity, Lyme disease may deserve consideration as one possible contributor, particularly when there has been potential tick exposure.

Patients sometimes notice subtle neurologic changes before other symptoms become more pronounced, including:

• Difficulty reading
• Slowed recall
• Spacing out during conversations
• Trouble multitasking
• Word-finding difficulty
• Reduced ability to sustain attention

Clinicians may consider Lyme disease when cognitive symptoms occur alongside:

• Fatigue and unrefreshing sleep
• Headaches
• Joint pain or migrating pain
• Dizziness or orthostatic intolerance
• Sensory hypersensitivity
• Fluctuating neurologic symptoms

Symptoms may change over time. Learn more about why Lyme symptoms come and go.

When brain fog becomes disabling

For some patients, cognitive symptoms interfere substantially with work, school, relationships, driving, and everyday functioning.

Tasks that once required little effort may become overwhelming. Patients may reduce work responsibilities, withdraw socially, or avoid cognitively demanding situations because of mental fatigue.

The invisible nature of these symptoms can be particularly frustrating. Someone may appear completely normal during a short conversation while being unable to sustain concentration for several hours or perform at their previous level professionally or academically.

These cognitive complications are discussed further in Lyme Encephalopathy Symptoms and Cognitive Problems.

Frequently Asked Questions

Can Lyme disease cause brain fog?

Yes. Cognitive problems including difficulty concentrating, memory problems, slowed processing, and word-finding difficulty have been reported in patients with Lyme disease.

Can Lyme disease cause memory loss?

Yes. Patients may report short-term memory problems, forgetfulness, difficulty finding words, or trouble recalling recent conversations. Memory complaints often occur together with brain fog and reduced mental stamina.

Can brain fog improve with Lyme disease treatment?

It can. Some patients report substantial cognitive improvement with treatment, while others improve only partially or not at all. Controlled studies of additional antibiotic treatment have produced mixed results, and a 2023 systematic review rated the overall certainty of evidence as low.

Do additional antibiotics improve Lyme disease brain fog?

Not consistently in clinical trials. Some studies identified improvement in certain cognitive outcomes, while others found no additional benefit compared with placebo or shorter treatment. The available evidence is limited and does not reliably identify which individual patients may respond.

Can cognitive improvement disappear after Lyme treatment stops?

It can in some patients. In one randomized Lyme encephalopathy trial, a cognitive treatment advantage was observed at 12 weeks but was no longer significant at 24 weeks after treatment had ended. This does not occur in every patient, but it illustrates that short-term and sustained improvement are different outcomes.

Can someone have severe brain fog with normal cognitive testing?

Yes. Subjective cognitive difficulty and objective neuropsychological test performance do not always match. Standardized testing may not fully reproduce the sustained attention, multitasking, mental endurance, and fatigue demands of everyday life.

Is Lyme disease brain fog the same as long COVID brain fog?

No. The symptoms can overlap, but Lyme disease and long COVID are different illnesses. Both may involve cognitive dysfunction and inflammatory or autonomic mechanisms, so careful evaluation is needed to determine the most likely contributors.

Do I need a positive Lyme test to have cognitive symptoms from Lyme disease?

Lyme disease testing has limitations, particularly early in infection. Test results should be interpreted within the broader clinical picture, including symptoms, timing, potential exposure, physical findings, and previous treatment.

Clinical Takeaway

Lyme disease brain fog can involve much more than occasional forgetfulness. Patients may experience difficulty with attention, memory, processing speed, word retrieval, executive function, and mental endurance.

Research examining cognitive response to additional antibiotic treatment has produced mixed findings. Some patients improved on certain cognitive measures, while other trials did not identify an advantage over placebo or longer treatment over shorter treatment. A 2023 systematic review concluded that the overall evidence remains limited and of low certainty.⁴

The absence of a consistent treatment effect across clinical trials should not lead clinicians to dismiss persistent cognitive symptoms. Patients with disabling brain fog deserve careful reassessment for Lyme disease activity, treatment response, neurologic and autonomic involvement, other tick-borne infections, and alternative explanations.

Related Articles

Learn more about neurologic Lyme disease and persistent cognitive symptoms:

How Lyme Disease Affects the Brain

Neurologic Lyme Disease

Autonomic Dysfunction in Lyme Disease

Post-Treatment Lyme Disease Syndrome (PTLDS)

Lyme Disease and Dementia

Lyme Encephalopathy Symptoms and Cognitive Problems

References

1. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444. doi:10.1056/NEJM199011223232102.
2. Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Primers. 2016;2:16090. doi:10.1038/nrdp.2016.90.
3. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135. doi:10.1586/14787210.2014.940900.
4. Rizvi ST, Shah JS, Shaaya S, Mollayeva T. Treating cognitive impairments in primary central nervous system infections: A systematic review of pharmacological interventions. Medicine (Baltimore). 2023;102(28):e34151. doi:10.1097/MD.0000000000034151.
5. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003. doi:10.1212/01.WNL.0000284604.61160.2d.
6. Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology. 2003;60(12):1916-1922. doi:10.1212/01.WNL.0000068030.26992.25.
7. Berende A, ter Hofstede HJM, Vos FJ, et al. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. Neurology. 2019;92(13):e1447-e1455. doi:10.1212/WNL.0000000000007186.

This article is for informational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Patients should discuss individual symptoms and treatment decisions with a qualified healthcare professional.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention